Insider · CIK 0001303811
Thomas Richard Kassberg
Files at RARE (Ultragenyx Pharmaceutical Inc.). First filing Mar 4, 2025, latest Mar 4, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RARE: Ultragenyx Pharmaceutical Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Ultragenyx Pharmaceutical Inc. | $254k 6,028 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | AGrant or award Common Stock | +18,443 | $0.00 | $0 | 271,266 | Mar 4, 2025 |
| Mar 3, 2025 | RARE Ultragenyx Pharmaceutical Inc. | SOpen-market sale Common Stock | -6,028 | $42.10 | $254k | 265,238 | Mar 4, 2025 |
| Mar 3, 2025 | RARE Ultragenyx Pharmaceutical Inc. | FTax withholding Common Stock | -508 | $42.92 | $22k | 264,730 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.